|
May 3
|
Moderna reports $1.2bn net loss in Q1 2024
|
|
May 3
|
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
|
|
May 2
|
Why Moderna Stock Blasted 13% Higher Today
|
|
May 2
|
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
|
|
May 2
|
Novo Nordisk slides while Moderna pops: Tale of two pharma stocks
|
|
May 2
|
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
|
|
May 2
|
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
|
|
May 2
|
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
|
|
May 2
|
S&P 500, Nasdaq Rise Intraday Amid Moderna Rally as Traders Await Apple Results
|
|
May 2
|
Moderna (MRNA) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Moderna CEO on the changing COVID market: Pandemic to endemic
|
|
May 2
|
Moderna Shares Jump After Better-Than-Expected Sales
|
|
May 2
|
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
|
|
May 2
|
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
|
|
May 2
|
Moderna Maintains Full-Year Sales Guidance Following First-Quarter Beat
|
|
May 2
|
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
|
|
May 2
|
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Moderna ends gene editing alliance with Metagenomi
|
|
May 2
|
Moderna posts quarterly sales beat, smaller loss than expected
|
|
May 2
|
Moderna quarterly sales beat expectations but plummet from previous year
|